title: The CYP2 gene of Saccharomyces cerevisiae encodes a cyclosporin A-sensitive peptidyl-prolyl cis-trans isomerase with an N-terminal signal sequence.
abstract: Cells of Saccharomyces cerevisiae contain a major cytosolic cyclophilin (Cyp)-related peptidyl-prolyl cis-trans isomerase (PPIase) which is the target for cyclosporin A (CsA) cytotoxicity and which is encoded by the CYP1 gene [Haendler et al., Gene 83 (1989) 39-46]. We recently identified a second Cyp-related gene in yeast, CYP2 [Koser et al., Nucleic Acids Res. 18 (1990) 1643] which predicts a protein with a hydrophobic leader sequence. A sequence lacking 33 codons from the 5'-end of the CYP2 open reading frame was generated by the polymerase chain reaction and engineered for expression in Escherichia coli. The corresponding recombinant truncated protein was purified and found to exhibit PPIase activity which was inhibited by CsA. The CYP2 gene is genetically unlinked to CYP1. As with CYP1, genomic disruption of CYP2 had no effect on haploid cell viability. Disruption of all three of the known yeast PPIase-encoding genes [CYP1, CYP2, and RBP1 for rapamycin-binding protein; Koltin et al., Mol. Cell. Biol. 11 (1991) 1718-1723] in the same haploid cell also resulted in no apparent cellular phenotype, suggesting either that none of these enzymes have an essential function or that additional PPIases can compensate for their specific absence. Whereas cells containing a genomic disruption of CYP1 exhibited a CsA-resistant phenotype, genomic disruption of CYP2 had no effect on CsA sensitivity. This suggests that the CYP1 gene product is the primary cellular target for CsA toxicity in yeast. Since both purified Cyps display CsA sensitivity in vitro, our data suggest that Cyp1 and Cyp2 differ in terms of their cellular function and/or localization.
authors.affiliation: Department of Molecular Genetics, SmithKline Beecham Pharmaceuticals, King of Prussia, PA 19406.
authors.forename: P L
authors.initials: PL
authors.lastname: Koser
authors.forename: D J
authors.initials: DJ
authors.lastname: Bergsma
authors.forename: R
authors.initials: R
authors.lastname: Cafferkey
authors.forename: W K
authors.initials: WK
authors.lastname: Eng
authors.forename: M M
authors.initials: MM
authors.lastname: McLaughlin
authors.forename: A
authors.initials: A
authors.lastname: Ferrara
authors.forename: C
authors.initials: C
authors.lastname: Silverman
authors.forename: K
authors.initials: K
authors.lastname: Kasyan
authors.forename: M J
authors.initials: MJ
authors.lastname: Bossard
authors.forename: R K
authors.initials: RK
authors.lastname: Johnson
authors.forename: T G
authors.initials: TG
authors.lastname: Porterd
authors.forename: M A
authors.initials: MA
authors.lastname: Levy
authors.forename: G P
authors.initials: GP
authors.lastname: Livi
mesh_terms: D000591:Amino Acid Isomerases / Q000235:genetics* / Q000378:metabolism; D000595:Amino Acid Sequence; D001483:Base Sequence; D002352:Carrier Proteins / Q000235:genetics* / Q000378:metabolism; D016572:Cyclosporine / Q000494:pharmacology; D004252:DNA Mutational Analysis; D004926:Escherichia coli / Q000378:metabolism; D015870:Gene Expression / Q000187:drug effects; D005800:Genes, Fungal; D008969:Molecular Sequence Data; D019696:Peptidylprolyl Isomerase; D021382:Protein Sorting Signals / Q000235:genetics*; D011994:Recombinant Proteins / Q000235:genetics; D012441:Saccharomyces cerevisiae / Q000187:drug effects / Q000201:enzymology* / Q000235:genetics
chemical_list: D002352:Carrier Proteins; D021382:Protein Sorting Signals; D011994:Recombinant Proteins; D016572:Cyclosporine; D000591:Amino Acid Isomerases; D019696:Peptidylprolyl Isomerase